Cellectis S.A. (EPA:ALCLS)
3.225
+0.365 (12.76%)
Last updated: Nov 10, 2025, 1:58 PM CET
Cellectis Revenue
Cellectis had revenue of $37.16M USD in the quarter ending September 30, 2025, with 105.88% growth. This brings the company's revenue in the last twelve months to $82.55M, up 129.04% year-over-year. In the year 2024, Cellectis had annual revenue of $49.22M with 435.37% growth.
Revenue (ttm)
$82.55M
Revenue Growth
+129.04%
P/S Ratio
2.94
Revenue / Employee
$371.85K
Employees
222
Market Cap
206.85M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.22M | 40.02M | 435.37% |
| Dec 31, 2023 | 9.19M | -16.53M | -64.26% |
| Dec 31, 2022 | 25.72M | -12.87M | -33.35% |
| Dec 31, 2021 | 38.60M | -20.97M | -35.20% |
| Dec 31, 2020 | 59.56M | 36.57M | 159.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |
Cellectis News
- 2 days ago - Cellectis (CLLS) Reports Strong Q3 Revenue Growth and Promising Clinical Data - GuruFocus
- 2 days ago - Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M - Seeking Alpha
- 2 days ago - Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 days ago - Cellectis Earnings Preview - Benzinga
- 7 days ago - Cellectis (CLLS) to Present Key Research at 2025 ASH Meeting - GuruFocus
- 7 days ago - Cellectis to Present a Development Update for eti-cel at ASH 2025 - GlobeNewsWire
- 10 days ago - Cellectis to Report Third Quarter Financial Results on November 7, 2025 - GlobeNewsWire
- 24 days ago - CLLS: Analyst Raises Price Target Significantly for Cellectis | CLLS Stock News - GuruFocus